MRP ₹258.5
(Inclusive of all Taxes)
₹38.8 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
निर्माता/विपणक :
लिविड फार्मास्यूटिकल्स प्राइवेट लिमिटेड
उपभोग प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
को या उसके बाद समाप्त हो जाएगा :
Jan-27
Have a query?
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Aliskiren with Bylenta MLN 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Bylenta MLN 50 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of amiloride with Bylenta MLN 50 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Bylenta MLN 50 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Potassium acetate can make Bylenta MLN 50 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Bylenta MLN 50 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Coadministration of enalapril with Bylenta MLN 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta MLN 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Bylenta MLN 50 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Bylenta MLN 50 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanEluxadoline
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Co-administration of Bylenta MLN 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Co-administration of Bylenta MLN 50 Tablet increases levels of eluxadoline by increasing metabolism.
How to manage the interaction:
Taking Bylenta MLN 50 Tablet with Eluxadoline together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking perindopril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking perindopril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with perindopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking Potassium citrate with Bylenta MLN 50 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta MLN 50 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Bylenta MLN 50 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Bylenta MLN 50 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking lisinopril with Bylenta MLN 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Bylenta MLN 50 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking quinapril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Bylenta MLN 50 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Bylenta MLN 50 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium iodide
Severe
How does the drug interact with Bylenta MLN 50 Tablet:
Taking Potassium Iodide with Bylenta MLN 50 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Taking Potassium Iodide with Bylenta MLN 50 Tablet can make high levels of potassium in the blood more likely.
How to manage the interaction:
Although taking Potassium iodide and Bylenta MLN 50 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
All Substitutes & Brand Comparisons
RX
Cilmikaa TM 50 Tablet 10's
Troikaa Pharmaceuticals Ltd
₹90.5
(₹8.15 per unit)
47% CHEAPERRX
Lndip-TM 50 Tablet 10's
Fusion Health Care Pvt Ltd
₹131
(₹11.79 per unit)
23% CHEAPERRX
Teldawn Lnb 50 Tablet 10's
Fusion Health Care Pvt Ltd
₹131
(₹11.79 per unit)
23% CHEAPER
शराब
Caution
शराब का सेवन करने से बचें क्योंकि इससे चक्कर आने की समस्या बढ़ सकती है।
गर्भावस्था
Caution
यदि आप गर्भवती हैं तो कृपया अपने डॉक्टर से परामर्श करें; आपका डॉक्टर केवल तभी दवा लिखेगा जब लाभ जोखिम से अधिक हो।
स्तनपान
Caution
यदि आप स्तनपान करा रही हैं तो कृपया अपने डॉक्टर से परामर्श करें; आपका डॉक्टर यह निर्णय लेगा कि स्तनपान कराने वाली माताओं को बायलेंटा एमएलएन 50 टैबलेट 15's दिया जा सकता है या नहीं।
ड्राइविंग
Caution
बायलेंटा एमएलएन 50 टैबलेट 15's से चक्कर आ सकता है, यदि आपको चक्कर आ रहा हो तो वाहन न चलाएं या भारी मशीनरी का संचालन न करें।
जिगर
Caution
खुराक समायोजन की आवश्यकता हो सकती है। बायलेंटा एमएलएन 50 टैबलेट 15's का उपयोग यकृत की दुर्बलता/यकृत रोग वाले रोगियों में सावधानी के साथ किया जाना चाहिए। यदि आपको यकृत संबंधी समस्याएँ हैं या इससे संबंधित कोई चिंता है, तो कृपया अपने डॉक्टर से परामर्श करें।
किडनी
Caution
खुराक समायोजन की आवश्यकता हो सकती है। बायलेंटा एमएलएन 50 टैबलेट 15's का उपयोग गुर्दे की दुर्बलता/गुर्दे की बीमारी वाले रोगियों में सावधानी के साथ किया जाना चाहिए। अगर आपको गुर्दे की समस्या है या इस बारे में कोई चिंता है तो कृपया अपने डॉक्टर से परामर्श करें।
बच्चे
Caution
बायलेंटा एमएलएन 50 टैबलेट 15's की बच्चों के लिए अनुशंसा नहीं की जाती है क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
